Brief: Acurx Pharmaceuticals Announces $1.1 Million Registered Direct Offering
07/03/2025 13:14
March 7 (Reuters) - Acurx Pharmaceuticals Inc ACXP.O: ACURX PHARMACEUTICALS, INC. ANNOUNCES $1.1 MILLION REGISTERED DIRECT OFFERING Source text: ID:nPn2HhCVha Further company coverage: ACXP.O (Reuters.Briefs@thomsonreuters.com)
Recent news on Acurx Pharmaceuticals
See all newsBrief: Acurx Pharmaceuticals Receives FDA Conditional Acceptance
Acurx Pharmaceuticals Inc reports results for the quarter ended June 30 - Earnings Summary
Acurx Pharmaceuticals Q2 loss widens on higher R&D costs
Acurx Pharmaceuticals Inc expected to post a loss of 38 cents a share - Earnings Preview
Brief: FDA Provides Further Regulatory Guidance To Acurx Pharmaceuticals For The Ibezapolstat Clinical Development Program